| Date Filed | Type | Description |
| 01/19/2023 |
4
| BATE KENNETH (Director) has filed a Form 4 on AVEO PHARMACEUTICALS, INC.|
Txns:
| Disposed/sold 375 shares
@ $15, valued at
$5.6k
Disposed/sold 1,250 options to buy
@ $25.9, valued at
$32.4k
Disposed/sold 1,250 options to buy
@ $15.7, valued at
$19.6k
Disposed/sold 2,515 options to buy
@ $16.1, valued at
$40.5k
Disposed/sold 2,000 options to buy
@ $20, valued at
$40k
Disposed/sold 6,402 options to buy
@ $9.2, valued at
$58.9k
Disposed/sold 7,785 options to buy
@ $7, valued at
$54.5k
Disposed/sold 4,000 options to buy
@ $22.7, valued at
$90.8k
Disposed/sold 4,000 options to buy
@ $7.6, valued at
$30.4k
Disposed/sold 4,000 options to buy
@ $7.52, valued at
$30.1k
Disposed/sold 12,500 options to buy
@ $7.27, valued at
$90.9k
|
|
| 08/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2022 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 06/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/19/2022 |
4
| BATE KENNETH (Director) has filed a Form 4 on Epizyme, Inc.|
Txns:
| Granted 8,994 shares
@ $0
Granted 41,006 options to buy
@ $0.56, valued at
$23k
|
|
| 07/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/30/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/19/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/18/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/12/2020 |
4
| BATE KENNETH (Director) has filed a Form 4 on CATABASIS PHARMACEUTICALS INC|
Txns:
| Granted 7,500 options to buy
@ $6.17, valued at
$46.3k
|
|
| 06/02/2020 |
4
| BATE KENNETH (Director) has filed a Form 4 on Epizyme, Inc.|
Txns:
| Granted 14,013 options to buy
@ $17.55, valued at
$245.9k
|
|
| 07/19/2019 |
4
| BATE KENNETH (Director) has filed a Form 4 on GENOCEA BIOSCIENCES, INC.|
Txns:
| Granted 5,625 options to buy
@ $3.66, valued at
$20.6k
|
|
| 07/01/2019 |
4
| BATE KENNETH (Director) has filed a Form 4 on MADRIGAL PHARMACEUTICALS, INC.|
Txns:
| Granted 10,000 options to buy
@ $100.45, valued at
$1M
|
|
| 06/13/2019 |
4
| BATE KENNETH (Director) has filed a Form 4 on AVEO PHARMACEUTICALS INC|
Txns:
| Granted 40,000 options to buy
@ $0.76, valued at
$30.4k
|
|
| 06/07/2019 |
4
| BATE KENNETH (Director) has filed a Form 4 on Epizyme, Inc.|
Txns:
| Granted 17,633 options to buy
@ $13.74, valued at
$242.3k
|
|
| 06/05/2019 |
4
| BATE KENNETH (Director) has filed a Form 4 on CATABASIS PHARMACEUTICALS INC|
Txns:
| Granted 7,500 options to buy
@ $6.53, valued at
$49k
|
|
| 06/25/2018 |
4
| BATE KENNETH (Director) has filed a Form 4 on GENOCEA BIOSCIENCES, INC.|
Txns:
| Granted 45,000 options to buy
@ $0.99, valued at
$44.6k
|
|
| 06/21/2018 |
4
| BATE KENNETH (Director) has filed a Form 4 on MADRIGAL PHARMACEUTICALS, INC.|
Txns:
| Granted 10,000 options to buy
@ $303.79, valued at
$3M
|
|
| 06/19/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/07/2018 |
4
| BATE KENNETH (Director) has filed a Form 4 on CATABASIS PHARMACEUTICALS INC|
Txns:
| Granted 14,000 options to buy
@ $1.48, valued at
$20.7k
|
|
| 05/31/2018 |
4
| BATE KENNETH (Director) has filed a Form 4 on Epizyme, Inc.|
Txns:
| Granted 12,500 options to buy
@ $17, valued at
$212.5k
|
|
| 07/28/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/30/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/26/2017 |
4
| BATE KENNETH (Director) has filed a Form 4 on Epizyme, Inc.|
Txns:
| Granted 12,500 options to buy
@ $13.65, valued at
$170.6k
|
|
| 06/23/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/19/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/15/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/04/2016 |
4/A
| BATE KENNETH (Director) has filed a Form 4 on MADRIGAL PHARMACEUTICALS, INC.|
Txns:
| Granted 20,000 options to buy
@ $0 |
|
|